Hillhouse Capital Advisors as of March 31, 2019
Portfolio Holdings for Hillhouse Capital Advisors
Hillhouse Capital Advisors holds 30 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Beigene (BGNE) | 16.3 | $586M | 4.4M | 132.00 | |
| Jd (JD) | 12.6 | $454M | 15M | 30.15 | |
| TAL Education (TAL) | 11.5 | $412M | 11M | 36.08 | |
| Iqiyi (IQ) | 8.4 | $300M | 13M | 23.92 | |
| Alibaba Group Holding (BABA) | 7.2 | $258M | 1.4M | 182.45 | |
| China Biologic Products | 7.0 | $251M | 2.8M | 91.25 | |
| Facebook Inc cl a (META) | 5.5 | $197M | 1.2M | 166.69 | |
| Mondelez Int (MDLZ) | 4.2 | $151M | 3.0M | 49.92 | |
| Blueprint Medicines (BPMC) | 3.3 | $120M | 1.5M | 80.05 | |
| Fibrogen (FGEN) | 3.0 | $109M | 2.0M | 54.35 | |
| Sea Ltd Adr Isin Us81141r1005 (SE) | 2.8 | $101M | 4.3M | 23.52 | |
| Melco Crown Entertainment (MLCO) | 2.8 | $99M | 4.4M | 22.59 | |
| Enstar Group (ESGR) | 2.6 | $95M | 544k | 174.00 | |
| Pinduoduo (PDD) | 2.2 | $78M | 3.1M | 24.80 | |
| Bilibili Ads (BILI) | 1.8 | $65M | 3.5M | 18.95 | |
| Myokardia | 1.4 | $51M | 976k | 51.99 | |
| Apellis Pharmaceuticals (APLS) | 1.4 | $50M | 2.6M | 19.50 | |
| Line Corp- | 1.2 | $43M | 1.2M | 35.21 | |
| Bright Scholar Ed Hldgs | 1.1 | $41M | 4.0M | 10.34 | |
| Kiniksa Pharmaceuticals (KNSA) | 0.9 | $33M | 1.8M | 18.06 | |
| Tencent Music Entertco L spon ad (TME) | 0.7 | $27M | 1.5M | 18.10 | |
| Gossamer Bio (GOSS) | 0.6 | $20M | 938k | 21.67 | |
| G1 Therapeutics (GTHX) | 0.4 | $16M | 949k | 16.60 | |
| Sohu (SOHU) | 0.4 | $13M | 802k | 16.58 | |
| Arvinas Ord (ARVN) | 0.3 | $9.2M | 625k | 14.76 | |
| Arcus Biosciences Incorporated (RCUS) | 0.1 | $5.3M | 425k | 12.49 | |
| Eidos Therapeutics | 0.1 | $4.2M | 179k | 23.45 | |
| Fang Hldgs | 0.1 | $2.0M | 1.5M | 1.35 | |
| Puxin Ltd ads | 0.0 | $874k | 126k | 6.93 | |
| New Oriental Education & Tech | 0.0 | $252k | 2.8k | 90.00 |
